GPR183 and rheumatoid arthritis: Relative to the other control groups, the expression levels of FAS, GPR183, and TFRC were significantly higher in total RA and RA subgroups, while no differences between ACPA-positive and -negative RA subgroups as well as early RA and established RA subgroups (Figure 5(a)).